Why it’s on the radar
Breye Therapeutics raised funding a Series A round of $73M, per EU-Startups — "Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases".
Original discovery source: eu-startups · Oct 2, 2026
Deterministic signals Startup Radar has derived from hiring, GitHub and website activity, never inferred, never scored.
Tracking started
Tracking started, no notable change detected yet.
Every event Startup Radar has recorded for Breye Therapeutics, most recent first.
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases
a Series A round, $73M
Danish biotech Breye raises EUR 67.5m for eye pill derived from Zealand Pharma
$73M